📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Alios Biopharma

1.1 - Company Overview

Alios Biopharma Logo

Alios Biopharma

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of novel medicines for viral diseases, leveraging platform technologies including small molecule activators of innate immunity antiviral pathways (RNase L activation), phosphate-protected nucleotide prodrug chemistry, and glycoprotein-engineering of interferons.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Alios Biopharma

Orchard Therapeutics Logo

Orchard Therapeutics

HQ: United Kingdom Website
  • Description: Provider of autologous ex vivo gene therapies for rare genetic diseases, including Libmeldy (EU-approved for MLD) and Strimvelis (EMA-approved for ADA-SCID), built on a hematopoietic stem cell gene therapy platform. Also conducts clinical trials, supports investigator-initiated research, and funds independent medical education on gene therapy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Orchard Therapeutics company profile →
Repare Therapeutics Logo

Repare Therapeutics

HQ: Canada Website
  • Description: Provider of oncology drug discovery and development targeting synthetic lethality, leveraging the SNIPRx CRISPR-based platform to identify gene pairs and develop targeted cancer therapies. Pipeline includes camonsertib (ATR inhibitor), lunresertib (PKMYT1 inhibitor), and preclinical RP-1664 (PLK4) and RP-3467 (Polθ), with ongoing clinical trials.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Repare Therapeutics company profile →
GeneLink Logo

GeneLink

HQ: United States Website
  • Description: Provider of genetic profile development, product development, business development, and support services.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full GeneLink company profile →
ProQR Logo

ProQR

HQ: The Netherlands Website
  • Description: Provider of RNA therapeutics and editing platforms for severe genetic rare diseases. Develops Axiomer RNA base-editing technology and Trident pseudouridylation platform, with programs AX-0810 for cholestatic diseases and AX-1412 for cardiovascular diseases, and product candidates QR-010, QR-110, and QR-313 for cystic fibrosis, Leber's congenital amaurosis type 10, and dyastrophic epidermolysis bullosa; partners with Eli Lilly.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ProQR company profile →
Genetic Analysis Logo

Genetic Analysis

HQ: Norway Website
  • Description: Provider of DNA-based molecular diagnostics for gut microbiota-related diseases, leveraging GA-map array technology to rapidly profile patient gut microbiota and link to health conditions. Offers GA-map Dysbiosis Test Lx for IBS and IBD, GA-map COVID-19 fecal PCR test, clinical research services for microbiota analysis, and companion diagnostics co-development.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Genetic Analysis company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Alios Biopharma

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Alios Biopharma

2.2 - Growth funds investing in similar companies to Alios Biopharma

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Alios Biopharma

4.2 - Public trading comparable groups for Alios Biopharma

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Alios Biopharma

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Alios Biopharma

What does Alios Biopharma do?

Alios Biopharma is a provider of novel medicines for viral diseases, leveraging platform technologies including small molecule activators of innate immunity antiviral pathways (RNase L activation), phosphate-protected nucleotide prodrug chemistry, and glycoprotein-engineering of interferons.

Who are Alios Biopharma's competitors?

Alios Biopharma's competitors and similar companies include Orchard Therapeutics, Repare Therapeutics, GeneLink, ProQR, and Genetic Analysis.

Where is Alios Biopharma headquartered?

Alios Biopharma is headquartered in United States.

How many employees does Alios Biopharma have?

Alios Biopharma has 1,000 employees 🔒.

When was Alios Biopharma founded?

Alios Biopharma was founded in 2010 🔒.

What sector and industry vertical is Alios Biopharma in?

Alios Biopharma is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Alios Biopharma

Who are the top strategic acquirers in Alios Biopharma's sector and industry

Top strategic M&A buyers and acquirers in Alios Biopharma's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Alios Biopharma?

Top strategic M&A buyers groups and sectors for Alios Biopharma include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Alios Biopharma's sector and industry vertical

Which are the top PE firms investing in Alios Biopharma's sector and industry vertical?

Top PE firms investing in Alios Biopharma's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Alios Biopharma's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Alios Biopharma's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Alios Biopharma's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Alios Biopharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Alios Biopharma's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Alios Biopharma?

The key public trading comparables and valuation benchmarks for Alios Biopharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Alios Biopharma for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Alios Biopharma with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Alios Biopharma's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Alios Biopharma with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Alios Biopharma's' sector and industry vertical?

Access recent funding rounds and capital raises in Alios Biopharma's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Alios Biopharma